Awareness of other GH-responsive conditions was notably lower, with only 38 (26.6%) identifying Turner syndrome, 25.2% recognizing Prader-Willi syndrome, 71 (49.7%) acknowledging chronic renal failure, and 64 (44.8%) recognizing Noonan syndrome. This evidence concerns the gene GH1 and Prader-Willi syndrome.